In last trading session, Sunshine Biopharma Inc (NASDAQ:SBFM) saw 67.72 million shares changing hands with its beta currently measuring 1.18. Company’s recent per share price level of $2.25 trading at $0.17 or 8.17% at ring of the bell on the day assigns it a market valuation of $6.09M. That closing price of SBFM’s stock is at a discount of -10922.22% from its 52-week high price of $248.00 and is indicating a premium of 15.56% from its 52-week low price of $1.90. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.94 million shares which gives us an average trading volume of 87.23K if we extend that period to 3-months.

Sunshine Biopharma Inc (NASDAQ:SBFM) trade information

Upright in the green during last session for gaining 8.17%, in the last five days SBFM remained trading in the green while hitting it’s week-highest on Wednesday, 04/02/25 when the stock touched $2.25 price level, adding 42.31% to its value on the day. Sunshine Biopharma Inc’s shares saw a change of -25.00% in year-to-date performance and have moved 5.63% in past 5-day. Sunshine Biopharma Inc (NASDAQ:SBFM) showed a performance of 5.19% in past 30-days. Number of shares sold short was 0.11 million shares which calculate 2.4 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 82.07% during past 5 years.

Sunshine Biopharma Inc (NASDAQ:SBFM)’s Major holders

Insiders are in possession of 7.22% of company’s total shares while institution are holding 1.12 percent of that, with stock having share float percentage of 1.21%. Investors also watch the number of corporate investors in a company very closely, which is 1.12% institutions for Sunshine Biopharma Inc that are currently holding shares of the company.